Cargando…

Cardiovascular Risk and Endothelial Dysfunction in Primary Sjogren Syndrome Is Related to the Disease Activity

The aim of our study was to evaluate if endothelial-dysfunction (ED) occurs in patients with primary Sjogren syndrome (pSS) and whether it is associated with the disease characteristics and activity. A total of 46 patients with pSS and 30 controls, without known cardiovascular disease, were enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Łuczak, Anna, Małecki, Rafał, Kulus, Michał, Madej, Marta, Szahidewicz-Krupska, Ewa, Doroszko, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235705/ https://www.ncbi.nlm.nih.gov/pubmed/34204342 http://dx.doi.org/10.3390/nu13062072

Ejemplares similares

Role of Erythrocytes in Nitric Oxide Metabolism and Paracrine Regulation of Endothelial Function
por: Gajecki, Damian, et al.
Publicado: (2022)

Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic Disorders
por: Janus, A., et al.
Publicado: (2016)

Intraplatelet L-Arginine-Nitric Oxide Metabolic Pathway: From Discovery to Clinical Implications in Prevention and Treatment of Cardiovascular Disorders
por: Gawrys, Jakub, et al.
Publicado: (2020)

Effect of the Renin-Angiotensin-Aldosterone System Reactivity on Endothelial Function and Modulative Role of Valsartan in Male Subjects with Essential Hypertension
por: Jasiczek, Jakub, et al.
Publicado: (2021)

The Human Carbonic Anhydrase II in Platelets: An Underestimated Field of Its Activity
por: Jakubowski, Maciej, et al.
Publicado: (2018)

Cardiovascular Disorders Triggered by Obstructive Sleep Apnea—A Focus on Endothelium and Blood Components
por: Mochol, Jakub, et al.
Publicado: (2021)

A Cross-Talk between the Erythrocyte L-Arginine/ADMA/Nitric Oxide Metabolic Pathway and the Endothelial Function in Subjects with Type 2 Diabetes Mellitus
por: Gajecki, Damian, et al.
Publicado: (2021)

Novel Molecular Mechanisms of Pulmonary Hypertension: A Search for Biomarkers and Novel Drug Targets—From Bench to Bed Site
por: Gajecki, Damian, et al.
Publicado: (2020)

Interactions between the Cyclooxygenase Metabolic Pathway and the Renin-Angiotensin-Aldosterone Systems: Their Effect on Cardiovascular Risk, from Theory to the Clinical Practice
por: Gawrys, Jakub, et al.
Publicado: (2018)

Effect of the transdermal low-level laser therapy on endothelial function
por: Szymczyszyn, Alicja, et al.
Publicado: (2016)

Role of the Platelets and Nitric Oxide Biotransformation in Ischemic Stroke: A Translative Review from Bench to Bedside
por: Bladowski, Maciej, et al.
Publicado: (2020)

Interferon Gamma Targeted Therapy: Is It Justified in Primary Sjögren’s Syndrome?
por: Sebastian, Agata, et al.
Publicado: (2022)

Role of the eNOS Uncoupling and the Nitric Oxide Metabolic Pathway in the Pathogenesis of Autoimmune Rheumatic Diseases
por: Łuczak, Anna, et al.
Publicado: (2020)

Effect of Regular Aerobic Activity in Young Healthy Athletes on Profile of Endothelial Function and Platelet Activity
por: Podgórska, Katarzyna, et al.
Publicado: (2017)

The Clinical and Immunological Activity Depending on the Presence of Interferon γ in Primary Sjögren’s Syndrome—A Pilot Study
por: Sebastian, Agata, et al.
Publicado: (2021)

Effect of Obstructive Sleep Apnea and CPAP Treatment on the Bioavailability of Erythrocyte and Plasma Nitric Oxide
por: Mochol, Jakub, et al.
Publicado: (2022)

Changes in the Plasma and Platelet Nitric Oxide Biotransformation Metabolites during Ischemic Stroke—A Dynamic Human LC/MS Metabolomic Study
por: Bladowski, Maciej, et al.
Publicado: (2022)

Endothelial Function in Children with Acute Lymphoblastic Leukemia (ALL) May Reflect the Clinical Outcome
por: Doroszko, Adrian, et al.
Publicado: (2018)

Low-Level Laser Irradiation Exerts Antiaggregative Effect on Human Platelets Independently on the Nitric Oxide Metabolism and Release of Platelet Activation Markers
por: Rola, Piotr, et al.
Publicado: (2017)

Corrigendum to “Low-Level Laser Irradiation Exerts Antiaggregative Effect on Human Platelets Independently on the Nitric Oxide Metabolism and Release of Platelet Activation Markers”
por: Rola, Piotr, et al.
Publicado: (2018)

New Candidates for Biomarkers and Drug Targets of Ischemic Stroke—A First Dynamic LC-MS Human Serum Proteomic Study
por: Turek-Jakubowska, Aleksandra, et al.
Publicado: (2022)

Platelet-Derived Drug Targets and Biomarkers of Ischemic Stroke—The First Dynamic Human LC-MS Proteomic Study
por: Gawryś, Karolina, et al.
Publicado: (2022)

Increased Intraplatelet ADMA Level May Promote Platelet Activation in Diabetes Mellitus
por: Gawryś, Jakub, et al.
Publicado: (2020)

Endothelial Dysfunction in Primary Sjögren’s Syndrome: Correlation with Serum Biomarkers of Disease Activity
por: Caraba, Alexandru, et al.
Publicado: (2023)

Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome
por: Blanc, Frederic, et al.
Publicado: (2013)

Visual Evoked Potentials as Potential Biomarkers of Visual Function in Patients with Primary Sjögren’s Syndrome
por: Dziadkowiak, Edyta, et al.
Publicado: (2021)

Platelet Carbonic Anhydrase II, a Forgotten Enzyme, May Be Responsible for Aspirin Resistance
por: Jakubowski, M., et al.
Publicado: (2017)

Cardiovascular Risk Factors in Women With Primary Sjögren's Syndrome: United Kingdom Primary Sjögren's Syndrome Registry Results
por: Juarez, M, et al.
Publicado: (2014)

Autonomic Nervous System Dysfunction in Primary Sjögren’s Syndrome
por: Davies, Kristen, et al.
Publicado: (2021)

Premature stroke and cardiovascular risk in primary Sjögren's syndrome
por: Zippel, Clara L., et al.
Publicado: (2022)

Chemosensory dysfunction in primary Sjögren’s syndrome: a topical review
por: Foguem, C., et al.
Publicado: (2022)

Cardiovascular Disease in Primary Sjögren’s Syndrome: Raising Clinicians’ Awareness
por: Casian, Mihnea, et al.
Publicado: (2022)

Cardiovascular Involvement in Sjögren’s Syndrome
por: Atzeni, Fabiola, et al.
Publicado: (2022)

Mild autonomic dysfunction in primary Sjögren's syndrome: a controlled study
por: Cai, Fin ZJ, et al.
Publicado: (2008)

Immune‐mediated axonal dysfunction in seropositive and seronegative primary Sjögren’s syndrome
por: Tani, Jowy, et al.
Publicado: (2020)

Olfactory dysfunction in primary Sjogren’s syndrome and its correlation with dry eye
por: Topan, Yunus E., et al.
Publicado: (2021)

Smell Dysfunction in Patients with Primary Sjögren’s Syndrome: Impact on Quality of Life
por: Al-Ezzi, Minan Y., et al.
Publicado: (2023)

Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome
por: Alunno, Alessia, et al.
Publicado: (2016)

EULAR Sjogren’s Syndrome Patient Reported Index (ESSPRI) and Other Patient-Reported Outcomes in the Assessment of Glandular Dysfunction in Primary Sjögren’s Syndrome
por: Ture, Hirut Yadeta, et al.
Publicado: (2023)

Ophthalmologic Manifestations of Primary Sjögren’s Syndrome
por: Roszkowska, Anna Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_95tprs6csj6dcs6ribhhoa6rrq